Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison With the Reference Drug
Clinical trial NCT06834100 · RECRUITING
Trial details
- NCT number
- NCT06834100
- Sponsor
- NPO Petrovax
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-12
- Primary completion
- 2025-12-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.